Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Men1 maintains exocrine pancreas homeostasis in response to inflammation and oncogenic stress.

Wasylishen AR, Sun C, Chau GP, Qi Y, Su X, Kim MP, Estrella JS, Lozano G.

Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6622-6629. doi: 10.1073/pnas.1920017117. Epub 2020 Mar 10.

PMID:
32156729
2.

PPARδ Interacts with the Hippo Coactivator YAP1 to Promote SOX9 Expression and Gastric Cancer Progression.

Song S, Wang Z, Li Y, Ma L, Jin J, Scott AW, Xu Y, Estrella JS, Song Y, Liu B, Johnson RL, Ajani JA.

Mol Cancer Res. 2020 Mar;18(3):390-402. doi: 10.1158/1541-7786.MCR-19-0895. Epub 2019 Dec 3.

PMID:
31796534
3.

Linitis Plastica: a Distinct Type of Gastric Cancer.

Ikoma N, Agnes A, Chen HC, Wang X, Blum MM, Das P, Minsky B, Estrella JS, Mansfield P, Ajani JA, Badgwell BD.

J Gastrointest Surg. 2019 Nov 21. doi: 10.1007/s11605-019-04422-7. [Epub ahead of print]

PMID:
31754987
4.

Expression of Epithelial-Mesenchymal Transition Markers in Treated Pancreatic Ductal Adenocarcinoma.

Wang M, Estrella JS, Katz MH, Kim M, Rashid A, Lee JE, Maitra A, Wistuba II, Wolff RA, Varadhachary GR, Wang H.

Pancreas. 2019 Nov/Dec;48(10):1367-1372. doi: 10.1097/MPA.0000000000001432.

PMID:
31688603
5.

Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portrait.

Huey RW, Makawita S, Xiao L, Matamoros A, Estrella JS, Overman MJ, Varadhachary GR, Raghav K.

BMC Cancer. 2019 Oct 17;19(1):965. doi: 10.1186/s12885-019-6155-6.

6.

Gastric cancer in the remnant stomach after pancreaticoduodenectomy: A case series.

Sonoda K, Samdani RT, Ikoma N, Kaya DM, Blum-Murphy M, Ajani JA, Badgwell BD, Katz MH, Rashid A, Estrella JS.

J Surg Oncol. 2019 Dec;120(7):1137-1141. doi: 10.1002/jso.25695. Epub 2019 Sep 9.

PMID:
31498442
7.

Characteristics and Survival of Gastric Cancer Patients with Pathologic Complete Response to Preoperative Therapy.

Stark AP, Ikoma N, Chiang YJ, Estrella JS, Das P, Minsky BD, Blum MM, Ajani JA, Mansfield P, Badgwell BD.

Ann Surg Oncol. 2019 Oct;26(11):3602-3610. doi: 10.1245/s10434-019-07638-8. Epub 2019 Jul 26.

PMID:
31350645
8.

Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response.

Wang R, Song S, Harada K, Ghazanfari Amlashi F, Badgwell B, Pizzi MP, Xu Y, Zhao W, Dong X, Jin J, Wang Y, Scott A, Ma L, Huo L, Vicente D, Blum Murphy M, Shanbhag N, Tatlonghari G, Thomas I, Rogers J, Kobayashi M, Vykoukal J, Estrella JS, Roy-Chowdhuri S, Han G, Zhang S, Mao X, Song X, Zhang J, Gu J, Johnson RL, Calin GA, Peng G, Lee JS, Hanash SM, Futreal A, Wang Z, Wang L, Ajani JA.

Gut. 2020 Jan;69(1):18-31. doi: 10.1136/gutjnl-2018-318070. Epub 2019 Jun 6.

9.

Loss of Menin Expression by Immunohistochemistry in Pancreatic Neuroendocrine Tumors: Comparison Between Primary and Metastatic Tumors.

Samdani RT, Wasylishen AR, Halperin DM, Dasari A, Yao JC, Rashid A, Estrella JS.

Pancreas. 2019 Apr;48(4):510-513. doi: 10.1097/MPA.0000000000001274.

PMID:
30946241
10.

A Phase II Trial of Ziv-Aflibercept in Patients With Advanced Pancreatic Neuroendocrine Tumors.

Halperin DM, Lee JJ, Ng CS, Strosberg JR, Estrella JS, Dagohoy CG, Dasari A, Yao JC.

Pancreas. 2019 Mar;48(3):381-386. doi: 10.1097/MPA.0000000000001258.

PMID:
30768575
11.

Laparoscopic Hyperthermic Intraperitoneal Chemotherapy is Safe for Patients with Peritoneal Metastases from Gastric Cancer and May Lead to Gastrectomy.

Newhook TE, Agnes A, Blum M, Estrella JS, Das P, Ho L, Ajani JA, Minsky BD, Mansfield P, Badgwell BD.

Ann Surg Oncol. 2019 May;26(5):1394-1400. doi: 10.1245/s10434-018-07140-7. Epub 2019 Jan 24.

PMID:
30680477
12.

Surgeon Assessment of Gastric Cancer Lymph Node Specimens with a Video of Technique.

Ikoma N, Estrella JS, Hofstetter WL, Ajani JA, Fournier KF, Mansfield PF, Skibber JM, Badgwell BD.

J Gastrointest Surg. 2018 Nov;22(11):2013-2019. doi: 10.1007/s11605-018-3880-0. Epub 2018 Jul 27.

PMID:
30054780
13.

The ypT category does not impact overall survival in node negative gastric cancer.

Ikoma N, Hofstetter WL, Estrella JS, Das P, Minsky BD, Fournier KF, Mansfield PF, Ajani JA, Badgwell BD.

J Surg Oncol. 2018 Jun;117(8):1721-1728. doi: 10.1002/jso.25081. Epub 2018 Jun 27.

PMID:
29949666
14.

Daxx Functions Are p53-Independent In Vivo.

Wasylishen AR, Estrella JS, Pant V, Chau GP, Lozano G.

Mol Cancer Res. 2018 Oct;16(10):1523-1529. doi: 10.1158/1541-7786.MCR-18-0281. Epub 2018 Jun 14.

15.

Repeat staging laparoscopy for gastric cancer after preoperative therapy.

Thiels CA, Ikoma N, Fournier K, Das P, Blum M, Estrella JS, Minsky BD, Ajani J, Mansfield P, Badgwell BD.

J Surg Oncol. 2018 Jul;118(1):61-67. doi: 10.1002/jso.25094. Epub 2018 Jun 7.

PMID:
29878364
16.

Potentially curable gastric adenocarcinoma treated without surgery.

Mizrak Kaya D, Nogueras-Gonzáles GM, Harada K, Amlashi FG, Thomas I, Rogers JE, Bhutani MS, Lee JH, Weston B, Minsky BD, Estrella JS, Blum Murphy MA, Matamoros A Jr, Devine CE, Das P, Badgwell BD, Ajani JA.

Eur J Cancer. 2018 Jul;98:23-29. doi: 10.1016/j.ejca.2018.04.012. Epub 2018 May 30.

PMID:
29859338
17.

Nodal Downstaging in Gastric Cancer Patients: Promising Survival if ypN0 is Achieved.

Ikoma N, Estrella JS, Hofstetter W, Das P, Minsky BD, Ajani JA, Fournier KF, Mansfield P, Badgwell BD.

Ann Surg Oncol. 2018 Jul;25(7):2012-2017. doi: 10.1245/s10434-018-6471-0. Epub 2018 May 10.

PMID:
29748883
18.

Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006-2014 using propensity score matching.

Ikoma N, Das P, Hofstetter W, Ajani JA, Estrella JS, Chen HC, Wang X, Callender RA, Zhu C, Roland CL, Fournier KF, Cormier JN, Mansfield P, Badgwell BD.

Gastric Cancer. 2018 Nov;21(6):1004-1013. doi: 10.1007/s10120-018-0832-z. Epub 2018 May 5.

19.

Central Lymph Node Metastasis in Gastric Cancer Is Predictive of Survival After Preoperative Therapy.

Ikoma N, Estrella JS, Blum M, Das P, Chen HC, Wang X, Fournier K, Mansfield P, Ajani J, Badgwell BD.

J Gastrointest Surg. 2018 Aug;22(8):1325-1333. doi: 10.1007/s11605-018-3764-3. Epub 2018 Apr 20.

PMID:
29679346
20.

Preoperative Chemoradiation Therapy Does Not Increase Risk of Anastomotic Leak in Patients With Gastric Cancer.

Ikoma N, Das P, Blum M, Estrella JS, Devine CE, Wang X, Fournier K, Mansfield P, Minsky BD, Ajani J, Badgwell BD.

Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):660-666. doi: 10.1016/j.ijrobp.2017.07.018. Epub 2017 Jul 20.

PMID:
29280460
21.

Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma.

Mizrak Kaya D, Nogueras-González GM, Harada K, Amlashi FG, Roy-Chowdhuri S, Estrella JS, Das P, Lee JH, Weston B, Bhutani MS, Matamoros A Jr, Thomas I, Lin Q, Badgwell BD, Ajani JA.

J Surg Oncol. 2018 Mar;117(4):678-684. doi: 10.1002/jso.24912. Epub 2017 Dec 4.

22.

Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors.

Ajani JA, Estrella JS, Chen Q, Correa AM, Ma L, Scott AW, Jin J, Liu B, Xie M, Sudo K, Shiozaki H, Badgwell B, Weston B, Lee JH, Bhutani MS, Onodera H, Suzuki K, Suzuki A, Ding S, Hofstetter WL, Johnson RL, Bresalier RS, Song S.

Br J Cancer. 2018 Jan;118(1):52-61. doi: 10.1038/bjc.2017.388. Epub 2017 Nov 14.

23.

Patterns of relapse in patients with localized gastric adenocarcinoma who had surgery with or without adjunctive therapy: costs and effectiveness of surveillance.

Elimova E, Slack RS, Chen HC, Planjery V, Shiozaki H, Shimodaira Y, Charalampakis N, Lin Q, Harada K, Wadhwa R, Estrella JS, Kaya DM, Sagebiel T, Lee JH, Weston B, Bhutani M, Murphy MB, Matamoros A, Minsky B, Das P, Mansfield PF, Badgwell BD, Ajani JA.

Oncotarget. 2017 Jul 13;8(46):81430-81440. doi: 10.18632/oncotarget.19226. eCollection 2017 Oct 6.

24.

Left Gastric Artery Lymph Nodes Should Be Included in D1 Lymph Node Dissection in Gastric Cancer.

Ikoma N, Blum M, Estrella JS, Wang X, Fournier KF, Mansfield PF, Ajani JA, Badgwell BD.

J Gastrointest Surg. 2017 Oct;21(10):1563-1570. doi: 10.1007/s11605-017-3539-2. Epub 2017 Aug 17.

PMID:
28819789
25.

Tumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma.

Harada K, Dong X, Estrella JS, Correa AM, Xu Y, Hofstetter WL, Sudo K, Onodera H, Suzuki K, Suzuki A, Johnson RL, Wang Z, Song S, Ajani JA.

Gastric Cancer. 2018 Jan;21(1):31-40. doi: 10.1007/s10120-017-0760-3. Epub 2017 Aug 11.

PMID:
28801853
26.

Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients.

Mizrak Kaya D, Dong X, Nogueras-González GM, Xu Y, Estrella JS, Harada K, Lopez A, Amlashi FG, Hofstetter WL, Maru DM, Nguyen QN, Lee JH, Weston B, Bhutani MS, Erasmus JJ, Thomas I, Rogers JE, Song S, Ajani JA.

Med Oncol. 2017 Aug;34(8):135. doi: 10.1007/s12032-017-0994-2. Epub 2017 Jul 6.

PMID:
28685276
27.

101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy.

Mizrak Kaya D, Wang X, Harada K, Blum Murphy MA, Das P, Minsky BD, Estrella JS, Lin Q, Amlashi FG, Lee JH, Weston B, Bhutani MS, Matamoros A Jr, Sagebiel T, Wu CC, Rogers JE, Thomas I, Maru DM, Skinner HD, Badgwell BD, Hofstetter WL, Ajani JA.

Oncology. 2017;93(4):243-248. doi: 10.1159/000475550. Epub 2017 Jul 6.

PMID:
28683449
28.

The significance of a nineteenth century definition in the era of genomics: linitis plastica.

Agnes A, Estrella JS, Badgwell B.

World J Surg Oncol. 2017 Jul 5;15(1):123. doi: 10.1186/s12957-017-1187-3. Review.

29.

Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy.

Ikoma N, Blum M, Estrella JS, Das P, Hofstetter WL, Fournier KF, Mansfield P, Ajani JA, Badgwell BD.

Gastric Cancer. 2018 Jan;21(1):74-83. doi: 10.1007/s10120-017-0743-4. Epub 2017 Jun 22.

PMID:
28643144
30.

Patterns of Initial Recurrence in Gastric Adenocarcinoma in the Era of Preoperative Therapy.

Ikoma N, Chen HC, Wang X, Blum M, Estrella JS, Fournier K, Mansfield P, Ajani J, Badgwell BD.

Ann Surg Oncol. 2017 Sep;24(9):2679-2687. doi: 10.1245/s10434-017-5838-y. Epub 2017 Mar 22.

PMID:
28332034
31.

Yield of Staging Laparoscopy and Lavage Cytology for Radiologically Occult Peritoneal Carcinomatosis of Gastric Cancer.

Ikoma N, Blum M, Chiang YJ, Estrella JS, Roy-Chowdhuri S, Fournier K, Mansfield P, Ajani JA, Badgwell BD.

Ann Surg Oncol. 2016 Dec;23(13):4332-4337. Epub 2016 Jul 6.

PMID:
27384751
32.

Race Is a Risk for Lymph Node Metastasis in Patients With Gastric Cancer.

Ikoma N, Blum M, Chiang YJ, Estrella JS, Roy-Chowdhuri S, Fournier K, Mansfield P, Ajani J, Badgwell BD.

Ann Surg Oncol. 2017 Apr;24(4):960-965. doi: 10.1245/s10434-016-5645-x. Epub 2016 Oct 24.

PMID:
27778127
33.

Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma.

Charalampakis N, Xiao L, Lin Q, Elimova E, Shimodaira Y, Harada K, Rogers JE, Mares J, Amlashi FG, Minsky BD, Das P, Hofstetter WL, Matamoros A Jr, Sagebiel TL, Blum-Murphy MA, Lee JH, Weston B, Bhutani MS, Mansfield PF, Estrella JS, Badgwell BD, Ajani JA.

Ann Surg Oncol. 2017 Aug;24(8):2291-2301. doi: 10.1245/s10434-016-5601-9. Epub 2016 Oct 21.

PMID:
27770339
34.

Survival rates in T1 and T2 gastric cancer: A Western report.

Ikoma N, Blum M, Chiang YJ, Estrella JS, Roy-Chowdhuri S, Fournier K, Mansfield P, Ajani JA, Badgwell BD.

J Surg Oncol. 2016 Oct;114(5):602-606. doi: 10.1002/jso.24382. Epub 2016 Jul 20.

PMID:
27439746
35.

Evolution of gastric surgery techniques and outcomes.

Shiozaki H, Shimodaira Y, Elimova E, Wadhwa R, Sudo K, Harada K, Estrella JS, Das P, Badgwell B, Ajani JA.

Chin J Cancer. 2016 Jul 26;35(1):69. doi: 10.1186/s40880-016-0134-y. Review.

36.

Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term Survivors.

Shiozaki H, Slack RS, Chen HC, Elimova E, Planjery V, Charalampakis N, Wadhwa R, Shimodaira Y, Skinner H, Lee JH, Weston B, Bhutani MS, Blum-Murphy M, Rogers JE, Maru DM, Matamoros A Jr, Sagebiel T, Estrella JS, Das P, Hofstetter WL, Mares JE, Mizrak Kaya D, Harada K, Lin Q, Minsky BD, Badgwell BD, Ajani JA.

Oncology. 2016;91(1):55-60. doi: 10.1159/000445998. Epub 2016 Apr 28.

37.

The Proportion of Signet Ring Cell Component in Patients with Localized Gastric Adenocarcinoma Correlates with the Degree of Response to Pre-Operative Chemoradiation.

Charalampakis N, Nogueras González GM, Elimova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum MA, Rogers JE, Harada K, Matamoros A Jr, Sagebiel T, Das P, Minsky BD, Lee JH, Weston B, Bhutani MS, Estrella JS, Badgwell BD, Ajani JA.

Oncology. 2016;90(5):239-47. doi: 10.1159/000443506. Epub 2016 Apr 6.

38.

Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases.

Shiozaki H, Elimova E, Slack RS, Chen HC, Staerkel GA, Sneige N, Shimodaira Y, Sagebiel T, Lee JH, Bhutani MS, Das P, Mansfield PF, Estrella JS, Badgwell BD, Ajani JA.

J Surg Oncol. 2016 Jan;113(1):29-35. doi: 10.1002/jso.24087. Epub 2015 Nov 25.

PMID:
26603684
39.

Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing.

Estrella JS, Tetzlaff MT, Bassett RL Jr, Patel KP, Williams MD, Curry JL, Rashid A, Hamilton SR, Broaddus RR.

Mol Cancer Ther. 2015 Dec;14(12):2887-95. doi: 10.1158/1535-7163.MCT-15-0615. Epub 2015 Oct 5.

40.

Initial Standardized Uptake Value of Positron Emission Tomography Influences the Prognosis of Patients with Localized Gastric Adenocarcinoma Treated Preoperatively.

Charalampakis N, Xiao L, Elimova E, Wadhwa R, Shiozaki H, Shimodaira Y, Blum MA, Planjery V, Rogers JE, Matamoros A Jr, Sagebiel T, Das P, Lee JH, Bhutani MS, Weston B, Estrella JS, Badgwell BD, Ajani JA.

Oncology. 2015;89(6):305-10. doi: 10.1159/000436972. Epub 2015 Sep 23.

41.

Malignant Solitary Fibrous Tumor of the Pancreas.

Estrella JS, Wang H, Bhosale PR, Evans HL, Abraham SC.

Pancreas. 2015 Aug;44(6):988-94. doi: 10.1097/MPA.0000000000000350.

PMID:
26166470
42.

Early versus Delayed Therapy of Advanced Gastric Cancer Patients--Does It Make a Difference?

Elimova E, Shiozaki H, Slack RS, Chen HC, Wadhwa R, Sudo K, Charalampakis N, Hiremath A, Estrella JS, Matamoros A, Sagebiel T, Das P, Rogers JE, Garris JL, Blum MA, Badgwell B, Ajani JA.

Oncology. 2015;89(4):215-20. doi: 10.1159/000434647. Epub 2015 Jul 8.

43.

Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma.

Tetzlaff MT, Pattanaprichakul P, Wargo J, Fox PS, Patel KP, Estrella JS, Broaddus RR, Williams MD, Davies MA, Routbort MJ, Lazar AJ, Woodman SE, Hwu WJ, Gershenwald JE, Prieto VG, Torres-Cabala CA, Curry JL.

Hum Pathol. 2015 Aug;46(8):1101-10. doi: 10.1016/j.humpath.2015.04.012. Epub 2015 May 6.

44.

Molecular biomarkers in gastric cancer.

Elimova E, Wadhwa R, Shiozaki H, Sudo K, Estrella JS, Badgwell BD, Das P, Matamoros A Jr, Song S, Ajani JA.

J Natl Compr Canc Netw. 2015 Apr;13(4):e19-29. Review.

PMID:
26052595
45.

Medical management of gastric cancer: a 2014 update.

Elimova E, Shiozaki H, Wadhwa R, Sudo K, Chen Q, Estrella JS, Blum MA, Badgwell B, Das P, Song S, Ajani JA.

World J Gastroenterol. 2014 Oct 14;20(38):13637-47. doi: 10.3748/wjg.v20.i38.13637. Review.

46.

Low-grade neuroendocrine tumors arising in intestinal adenomas: evidence for alterations in the adenomatous polyposis coli/β-catenin pathway.

Estrella JS, Taggart MW, Rashid A, Abraham SC.

Hum Pathol. 2014 Oct;45(10):2051-8. doi: 10.1016/j.humpath.2014.07.001. Epub 2014 Jul 24.

PMID:
25149552
47.

Progesterone receptor and PTEN expression predict survival in patients with low- and intermediate-grade pancreatic neuroendocrine tumors.

Estrella JS, Broaddus RR, Mathews A, Milton DR, Yao JC, Wang H, Rashid A.

Arch Pathol Lab Med. 2014 Aug;138(8):1027-36. doi: 10.5858/arpa.2013-0195-OA.

PMID:
25076292
48.

Expression of estrogen-induced genes and estrogen receptor β in pancreatic neuroendocrine tumors: implications for targeted therapy.

Estrella JS, Ma LT, Milton DR, Yao JC, Wang H, Rashid A, Broaddus RR.

Pancreas. 2014 Oct;43(7):996-1002. doi: 10.1097/MPA.0000000000000203.

49.

Anti-angiogenic agent ramucirumab: meaningful or marginal?

Wadhwa R, Elimova E, Shiozaki H, Sudo K, Blum MA, Estrella JS, Chen Q, Song S, Ajani JA.

Expert Rev Anticancer Ther. 2014 Apr;14(4):367-79. doi: 10.1586/14737140.2014.896207. Epub 2014 Mar 7. Review.

PMID:
24605771
50.

Solid pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution.

Estrella JS, Li L, Rashid A, Wang H, Katz MH, Fleming JB, Abbruzzese JL, Wang H.

Am J Surg Pathol. 2014 Feb;38(2):147-57. doi: 10.1097/PAS.0000000000000141.

PMID:
24418850

Supplemental Content

Loading ...
Support Center